Home » PED MED: WADING THROUGH ADHD DRUG OPTIONS
PED MED: WADING THROUGH ADHD DRUG OPTIONS
Parents, patients and physicians who decide to launch a pharmaceutical course of treatment for attention-deficit/hyperactivity disorder must wade through a large pool of offerings -- twice as many as available in Europe -- with little scientific data to guide them, market analysts say.
Monsters and Critics (http://news.monstersandcritics.com/lifestyle/consumerhealth/article_1155001.php/Ped_Med_Wading_through_ADHD_drug_options)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May